| DRUG WATCH |
|
| Year : 2015 | Volume
: 47
| Issue : 5 | Page : 567-568 |
Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline
Ranjita Santra (Dhali)1, Prithwijit Banerjee2, Santanu Munshi1, Patralekha Ray Chaudhuri3
1 Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India
2 Department of Pharmacology, Sagar Dutta Medical College, Kolkata, West Bengal, India
3 Department of Pharmacology, Calcutta National Medical College, Kolkata, West Bengal, India
Correspondence Address:
Dr. Ranjita Santra (Dhali)
Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal
India
 Source of Support: Nil., Conflict of Interest: There are no conflicts of interest.  | Check |
DOI: 10.4103/0253-7613.165193
Sertraline is a selective serotonin reuptake inhibitor. It has been shown to blunt postprandial hyperglycemia in rats and to potentiate the hypoglycemic effects of sulfonylurea agents in humans. Here, we report a case of a 33-year-old nondiabetic patient with no history of glucose intolerance, who experienced multiple episodes of hypoglycemia that resolved after discontinuation of the drug. Healthcare professionals should consider sertraline among the possible causes of hypoglycemia occurring in patients receiving antidepressants.
[FULL TEXT] [PDF]*
|
